ITM 63
Alternative Names: ITM-63; Tb161-labelled radiopharmaceutical theranosticLatest Information Update: 28 Mar 2025
At a glance
- Originator ITM Solucin
- Class Antineoplastics; Diagnostic agents; Imaging agents; Isotopes; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Neuroendocrine tumours
Most Recent Events
- 25 Mar 2025 Phase-I clinical trials in Neuroendocrine tumours (Parenteral) (ITM Solucin pipeline, March 2025)